US 8841295
5-lipoxygenase-activating protein (FLAP) inhibitors
granted A61PA61P1/00A61P1/04
Quick answer
US patent 8841295 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by Panmira Pharmaceuticals, LLC expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Panmira Pharmaceuticals, LLC
- Grant date
- Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P1/06, A61P11/00